Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew revision tag Revision: v3.6.3 has been added, replacing Revision: v3.6.0. This indicates a minor update to the page’s revision history or release notes.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status now shows no further participant enrollment; new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was adjusted, with the revision updated to v3.6.0.SummaryDifference0.4%

- Check33 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a small update to the page's underlying revision rather than a change to study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, signaling a new release of the site rendering. The content and study details remain unchanged aside from metadata.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page footer revision label has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check111 days agoChange DetectedThe page now shows a revision label, Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.